The stock of ARCH THERAPEUTICS INCORPORATED (OTCMKTS:ARTH) registered an increase of 2.85% in short interest. ARTH’s total short interest was 1.43M shares in September as published by FINRA. Its up 2.85% from 1.39M shares, reported previously. With 1.35M shares average volume, it will take short sellers 1 days to cover their ARTH’s short positions. About 668,664 shares traded hands. Arch Therapeutics Inc (OTCMKTS:ARTH) has risen 218.51% since February 8, 2016 and is uptrending. It has outperformed by 202.02% the S&P500.
Arch Therapeutics, Inc. is a life science medical device company. The company has a market cap of $79.18 million. The Firm is focused on developing an approach for the cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. It currently has negative earnings. The Company’s technology is based on a self-assembling peptide that creates a physical, mechanical barrier, which could be applied to seal organs or wounds that are leaking blood and other fluids.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.